(1) The biocompatibility profiles of RBC caused by the nanoparticles were demonstrated at different concentrations of 5 to 30 µg/mL. (2) Lf-PPN, Lf-PPN with OX26, and Lf-PPN with DE2B4 detected only insignificant hemolysis, which shows extreme biocompatibility for in vivo profiles.